reta glp-1 Gwyneth Paltrow, Andrew Huberman & Retatrutide Retatrutide, an experimental weight-loss drug,

Jos Luis Simarro (Spain) Dr

Even though India prohibits direct-to-consumer marketing of prescription drugs, regulators are watching out for messaging to induce misuse

Rhode Island's Medicaid agency proposes ending GLP-1 coverage for weight loss while keeping diabetes uses, citing soaring costs.

If you came to struggle with gastroparesis, bowe obstruction or vision loss as a result of using Victoza, you might be eligible to file a claim with the manufacturer, which can help you obtain financial compensation

This retrospective cohort study evaluated changes in time in therapeutic range (TTR) among patients receiving warfarin during the 6 months before and after GLP-1 RA initiation, using real-world data from the TriNetX Research Network

list price as of April 2026 (Novo Nordisk published pricing)